EMA accepts Astellas/Seagen’s enfortumab vedotin for review
Marketing authorisation application is seeking approval for advanced urothelial cancer
26th March 2021
Latest news
NHS England makes Keytruda available for advanced colorectal cancer during pandemic
Interim treatment agreement reached for eligible patients during COVID-19 pandemic
26th March 2021
Relugolix shows potential long-term benefit in women with uterine fibroids
Study compared women who continued on relugolix combination therapy with women who discontinued treatment
25th March 2021
Cambridge start-up PhoreMost raises £33m to progress PLK1 programme
Lead ‘Allosteric PLK1’ asset will initially target brain cancer
25th March 2021
UK Health Security Agency launches to address ‘future health threats’
New national agency will plan for, prevent and respond to external health threats including infectious diseases
25th March 2021
AstraZeneca’s updated COVID-19 vaccine trial results show 76% efficacy
Initial results from US trial published earlier this week said the vaccine was 79% effective
25th March 2021
Report urges pharma companies to utilise synthetic data in clinical trials
Report outlines two cases for using synthetic data in the clinical trial process
24th March 2021
Zealand Pharma’s hypoglycaemia therapy Zegalogue scores approval in the US
Therapy authorised for the treatment of severe hypoglycaemia in people with diabetes
24th March 2021
AZ to issue primary analysis for COVID-19 vaccine following ‘outdated information’ concerns
US data and safety monitoring board expressed ‘concern’ over initial trial data
24th March 2021
FDA refuses Novo Nordisk’s once-weekly semaglutide
Company had been aiming for approval in type 2 diabetes
24th March 2021
Roche ends tominersen study in manifest Huntington’s disease
Decision was based on the results of a pre-planned review of study data
23rd March 2021
Researchers identify molecular ‘cookie cutter’ technique for COVID-19 drug discovery
Researchers are aiming to isolate a stable form of the COVID-19 encounter complex
23rd March 2021
Daiichi Sankyo inks digital partnership for atrial fibrillation
Collaborative agreement will focus on improving detection and diagnosis of AF
23rd March 2021
AstraZeneca’s COVID-19 vaccine shows 79% efficacy in US trial
Jab was also found to have 100% efficacy at preventing severe disease and hospitalisation
23rd March 2021
FDA nod for Kiniksa’s Arcalyst in recurrent pericarditis
Recurrent pericarditis is an autoinflammatory cardiovascular disease
22nd March 2021
